Corvus Pharmaceuticals (CRVS) Insider Trading & Ownership $4.31 +0.21 (+5.12%) Closing price 08/4/2025 04:00 PM EasternExtended Trading$9.72 +5.41 (+125.52%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Corvus Pharmaceuticals (NASDAQ:CRVS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage31.30%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$4.89M Get CRVS Insider Trade Alerts Want to know when executives and insiders are buying or selling Corvus Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CRVS Insider Buying and Selling by Quarter Corvus Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/27/2025Peter A ThompsonDirectorSell1,176,332$4.16$4,893,541.12 (Data available from 1/1/2013 forward) CRVS Insider Trading Activity - Frequently Asked Questions Who is on Corvus Pharmaceuticals' Insider Roster? The list of insiders at Corvus Pharmaceuticals includes Leiv Lea, Linda Grais, Peter A Thompson, Richard A Md Miller, and William Benton Jones. Learn more on insiders at CRVS. What percentage of Corvus Pharmaceuticals stock is owned by insiders? 31.30% of Corvus Pharmaceuticals stock is owned by insiders. Learn more on CRVS's insider holdings. Which Corvus Pharmaceuticals insiders have been buying company stock? The following insiders have purchased CRVS shares in the last 24 months: Richard A Md Miller ($999,306.82), and William Benton Jones ($34,600.00). How much insider buying is happening at Corvus Pharmaceuticals? Insiders have purchased a total of 597,634 CRVS shares in the last 24 months for a total of $1,033,906.82 bought. Which Corvus Pharmaceuticals insiders have been selling company stock? The following insider sold CRVS shares in the last 24 months: Peter A Thompson ($4,893,541.12). How much insider selling is happening at Corvus Pharmaceuticals? Insiders have sold a total of 1,176,332 Corvus Pharmaceuticals shares in the last 24 months for a total of $4,893,541.12 sold. Corvus Pharmaceuticals Key ExecutivesDr. Richard A. Miller M.D. (Age 73)Co-Founder, President, CEO & Chairman of the Board Compensation: $116.31kDr. Peter A. Thompson FACP (Age 64)M.D., Co-Founder & Independent Director Compensation: $47kMr. Leiv Lea (Age 70)Chief Financial Officer Compensation: $400.21kDr. William Benton Jones Ph.D. (Age 58)Senior Vice President of Pharmaceutical Development Compensation: $355.7kDr. James T. Rosenbaum M.D.Senior Vice President of ResearchMr. Jeffrey S. ArcaraChief Business Officer More Insider Trading Tools from MarketBeat Related Companies PRAX Insider Transactions AVDL Insider Transactions PAHC Insider Transactions ARDX Insider Transactions GPCR Insider Transactions AMPH Insider Transactions VERV Insider Transactions SYRE Insider Transactions AKBA Insider Transactions RCUS Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Strategy Insiders Buy In While Analysts Predict Big UpsideThe Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months This page (NASDAQ:CRVS) was last updated on 8/5/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredEx-Hedge Fund Manager Uncovers $100 Trillion Land ShiftTrump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to u...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Corvus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Corvus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
